Dept. of Medicine, Univ. of Virginia Health Sciences Center, Charlottesville, VA 22908-1409, USA.
Am J Physiol Renal Physiol. 2012 Dec 15;303(12):F1652-7. doi: 10.1152/ajprenal.00204.2012. Epub 2012 Oct 17.
Effects of low salt (LS) on (pro)renin receptor (PRR) expression are not well established. We hypothesized that LS enhances renal PRR expression via the cGMP-protein kinase G (PKG) signaling pathway. Sprague-Dawley rats were fed a normal-salt (NS) or LS diet associated with intrarenal cortical administration of vehicle (V), the nitric oxide (NO) synthase inhibitor nitro-l-arginine methyl ester (l-NAME), the NO donor S-nitroso-N-acetyl-dl-penicillamine (SNAP), the cGMP analog 8-bromoguanosine (8-Br)-cGMP, the guanylyl cyclase inhibitor 1H-[1, 2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), or a PKG inhibitor (PKGi) for 6 days via osmotic minipump. We evaluated the effects of each treatment on renal interstitial fluid (RIF) levels of nitrate/nitrite and cGMP and renal PRR expression. There were no significant changes in blood pressure with any of the treatments. Urinary sodium excretion was significantly lower in rats given a LS diet. Compared with NS + V, RIF nitrate/nitrite and cGMP levels increased in LS + V rats. In NS groups, RIF nitrate/nitrite and cGMP levels did not change with l-NAME, ODQ, or PKGi and increased in response to SNAP. 8-Br-cGMP increased RIF cGMP but not RIF nitrate/nitrite. In LS groups, RIF nitrate/nitrite decreased with l-NAME and did not change with ODQ or PKGi whereas RIF cGMP decreased with l-NAME, ODQ, and PKGi. PRR mRNA and protein increased in LS + V. In NS rats, PRR mRNA and protein increased in response to 8-Br-GMP and were not affected by any of other treatments. In LS rats, PRR mRNA and protein decreased significantly in response to l-NAME, ODQ, and PKGi. We conclude that LS intake enhances renal expression of PRR via cGMP-PKG signaling pathway.
低盐(LS)对(前)肾素受体(PRR)表达的影响尚未得到充分证实。我们假设 LS 通过 cGMP-蛋白激酶 G(PKG)信号通路增强肾 PRR 的表达。Sprague-Dawley 大鼠给予正常盐(NS)或 LS 饮食,并通过渗透微型泵在肾皮质内给予载体(V)、一氧化氮(NO)合酶抑制剂硝基-l-精氨酸甲酯(l-NAME)、NO 供体 S-亚硝基-N-乙酰基-dl-青霉胺(SNAP)、cGMP 类似物 8-溴鸟苷酸(8-Br-cGMP)、鸟苷酸环化酶抑制剂 1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ)或 PKG 抑制剂(PKGi)6 天。我们评估了每种治疗方法对肾间质液(RIF)硝酸盐/亚硝酸盐和 cGMP 水平以及肾 PRR 表达的影响。任何治疗方法都没有显著改变血压。LS 饮食组大鼠的尿钠排泄明显减少。与 NS+V 相比,LS+V 大鼠的 RIF 硝酸盐/亚硝酸盐和 cGMP 水平升高。在 NS 组中,RIF 硝酸盐/亚硝酸盐和 cGMP 水平不受 l-NAME、ODQ 或 PKGi 影响,而对 SNAP 有反应时增加。8-Br-cGMP 增加了 RIF cGMP,但不增加 RIF 硝酸盐/亚硝酸盐。在 LS 组中,RIF 硝酸盐/亚硝酸盐随着 l-NAME 减少,而不随 ODQ 或 PKGi 改变,而 RIF cGMP 随着 l-NAME、ODQ 和 PKGi 减少。LS+V 组 PRR mRNA 和蛋白增加。在 NS 大鼠中,PRR mRNA 和蛋白对 8-Br-GMP 有反应,不受其他任何治疗方法的影响。在 LS 大鼠中,PRR mRNA 和蛋白对 l-NAME、ODQ 和 PKGi 反应明显减少。我们的结论是,LS 摄入通过 cGMP-PKG 信号通路增强肾 PRR 的表达。